Status:
COMPLETED
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine what the study drug does to the body, what the body does to the study drug, and if the study drug is safe and well tolerated when given to adult healthy volun...
Eligibility Criteria
Inclusion
- Healthy male subjects.
- Healthy non-child bearing female subjects.
- 18 to 35 years of age.
Exclusion
- Heart disease.
- Clotting disorders.
- Use of nicotine products.
- Diabetes.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT01897142
Start Date
September 1 2013
End Date
March 1 2015
Last Update
April 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Clinical Research Unit
Brussels, Belgium, B-1070